|
| related topics |
| {product, liability, claim} |
| {operation, international, foreign} |
| {regulation, government, change} |
| {customer, product, revenue} |
| {product, market, service} |
| {operation, natural, condition} |
| {acquisition, growth, future} |
|
|
If we are unable to successfully expand our business, through internal research and development, marketing partnerships and acquisitions, our business may be materially and adversely affected.
If we are unable to successfully keep pace with technological advances in the medical field and the standards for transfusion medicine, our business, financial condition and results of operation could be adversely affected.
As a medical device manufacturer we are subject to a number of existing laws and regulations. Non-compliance with those laws or regulations could adversely affect our financial condition and results of operations.
We are subject to various actions by government authorities that regulate medical devices including: product recalls, orders to cease manufacturing or distribution activities, and other sanctions or penalties.
Many of our competitors have significantly greater financial and other resources. Their greater financial resources may allow them to more rapidly develop new technologies, and more quickly address changes in customer requirements.
As a global corporation, we are exposed to fluctuations in currency exchange rates, which could adversely affect our cash flows and results of operations.
Plastics are the principal component of our Disposables, which are the main source of our revenues.
Loss of a significant customer could adversely affect our business.
We are subject to the risks of international economic and political conditions.
We are subject to the risks associated with communicable diseases. A significant outbreak of a disease could reduce the demand for our products and affect our ability to provide our customers with products and services.
We sell our products in certain emerging economies.
In many of the international markets in which we do business, including certain parts of Europe, Russia and Asia, our employees, agents or distributors offer to sell our products in response to public tenders issued by various governmental agencies.
Full 10-K form ▸
|
|
| related documents |
| 10795--11/24/2010--BECTON_DICKINSON_&_CO |
| 874716--2/19/2010--IDEXX_LABORATORIES_INC_/DE |
| 780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 874716--2/20/2009--IDEXX_LABORATORIES_INC_/DE |
| 313143--5/25/2007--HAEMONETICS_CORP |
| 10795--11/30/2006--BECTON_DICKINSON_&_CO |
| 10795--11/23/2007--BECTON_DICKINSON_&_CO |
| 718924--12/27/2006--SPAN_AMERICA_MEDICAL_SYSTEMS_INC |
| 10795--11/25/2009--BECTON_DICKINSON_&_CO |
| 780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 1000736--3/2/2006--CAREMARK_RX_INC |
| 1270597--3/23/2007--MERISANT_CO |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 40533--2/23/2007--GENERAL_DYNAMICS_CORP |
| 40533--2/22/2008--GENERAL_DYNAMICS_CORP |
| 40533--2/20/2009--GENERAL_DYNAMICS_CORP |
| 911160--6/2/2010--RF_MICRO_DEVICES_INC |
| 10795--11/26/2008--BECTON_DICKINSON_&_CO |
| 10456--2/19/2009--BAXTER_INTERNATIONAL_INC |
| 1006045--4/10/2008--IRIDEX_CORP |
| 880432--9/28/2009--MISONIX_INC |
| 1110783--10/26/2007--MONSANTO_CO_/NEW/ |
| 856982--3/4/2009--MERIT_MEDICAL_SYSTEMS_INC |
| 780127--1/5/2010--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 862668--9/29/2008--ESCALON_MEDICAL_CORP |
| 768408--6/24/2010--CYANOTECH_CORP |
| 31791--3/1/2010--PERKINELMER_INC |
| 1270597--3/31/2006--MERISANT_CO |
| 862668--10/12/2010--ESCALON_MEDICAL_CORP |
| 949874--3/14/2006--YOUNG_INNOVATIONS_INC |
|